5 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 33416182 | Targeting the mitogen‑activated protein kinase kinase and protein kinase A pathways overcomes acquired resistance to Selumetinib in low‑grade glioma cells. | 2021 Feb | 1 |
| 2 | 29737325 | The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib. | 2018 May 8 | 1 |
| 3 | 22260668 | Tumour cell responses to MEK1/2 inhibitors: acquired resistance and pathway remodelling. | 2012 Feb | 1 |
| 4 | 21447798 | Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells. | 2011 Mar 29 | 1 |
| 5 | 21674991 | A correction to the research article titled: "Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells" by A. S. Little, K. Balmanno, M. J. Sale, S. Newman, J. R. Dry, M. Hampson, P. A. W. Edwards, P. D. Smith, S. J. Cook. | 2011 | 1 |